News

Under the agreement, Merrion will receive up to $58 million for the first product developed under the agreement to reach the market based on achievement of certain development,

Based on this designation, the FDA Prescription Drug User Fee Act target action date is March 23, 2009, or six months from the biologics license application (BLA) submission

The primary endpoint of progression free survival (PFS) was assessed by the treating physicians in the study (investigator-assessed). The safety profile of Avastin was consistent with previous experience

The allowed claims within this patent application cover compositions of platelet derived growth factor (PDGF) combined with matrix materials having defined characteristics, which cover the company’s recombinant protein-device

Dr Williams has more than 20 years of experience in the biotechnology industry. At Immunex, he was head of discovery research, executive vice president and chief technology officer

SonoSite said that its portable ultrasound products provide point-of-care imaging across multiple clinical applications. Using SonoSite hand-carried ultrasound, the HealthTrust membership will have access at the point-of-care to

Mr Federici joined West Pharmaceutical Services as vice president and CFO in August 2003. He has more than 20 years of public accounting experience, and was previously national

After their publication and once they are issued, the patent claims will have a term of 20 years from the international filing date of March 11, 2005. Solomon

Dr Wotton previously served as president and COO. Concurrently, Jack Stover has resigned as both CEO and vice chairman of the board of directors. Dr Wotton joined Antares